ZNF598 and amyotrophic lateral sclerosis: OE of ZNF598 restored mitochondrial morphology (Fig. S4d), and reduced mito-Ca2+ level (Fig. 4h) and MMP (Fig. 4i) in C9-ALS/FTD patient fibroblasts.